Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 155
- 试验地点
- 1
- 主要终点
- Performing a self-measurement of blood pressure
研究概览
简要总结
Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in the urine. It can lead to emergency hospitalization in severe cases and cause major complications or even death in the mother and the fetus.
Several studies observing the outcome of patients with pre-eclampsia have shown an increased long-term cardiovascular risk in these patients, justifying regular medical follow-up with the treating physician and specialists, mainly cardiologists.
The main objective of this research is to describe the cardiovascular risk assessment actions implemented by the treating general practitioner in the year following pre-eclampsia (blood pressure measurement in the office, self-measurement of blood pressure, ABPM, cardiological consultation, biological monitoring of blood (creatininemia, LDL, fasting glycemia) or urine (albuminurie/creatininurie ratio), and screening and management of possible smoking).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years hospitalized for preeclampsia at the Nancy regional maternity hospital
排除标准
- •Fetal death in utero;
- •Adult Person subject to a legal protection measure (guardianship, curatorship, safeguard of justice);
- •Person deprived of liberty by a judicial or administrative decision;
- •Person subject to psychiatric care under constraint by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code.
结局指标
主要结局
Performing a self-measurement of blood pressure
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as self-measurement of blood pressure. Composite outcome with 2, 3, 4, 5 and 6
Performing a cardiological consultation
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as cardiological consultation. Composite outcome with 2, 3, 4, 5 and 6
Performing a biological monitoring of blood (creatinine, LDL cholesterol, fasting glucose, albuminuria creatinuria ratio)
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as biological monitoring of blood (creatinine, LDL, fasting glucose) or urine (Albuminuria/creatininuria ratio). Composite outcome with 2, 3, 4, 5 and 6.
Performing a blood pressure measurement by the general practitioner
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as blood pressure measurement in the office. Composite outcome with 2, 3, 4, 5 and 6
Performing a ambulatory measurement of blood pressure
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as ambulatory measurement of blood pressure. Composite outcome with 2, 3, 4, 5 and 6
Screening and management of possible smoking
时间窗: Up to one year following pre eclampsia
Description: Describe the cardiovascular risk assessment actions implemented by the general practitioner in the year following pre-eclampsia within the following specific monitoring tools such as screening and management of possible smoking. Composite outcome with 1, 2, 3, 4 and 5
次要结局
- Pre eclampsia information mode(Up to 5 years following pre eclampsia)
- Performing a blood pressure measurement(Up to one year following pre eclampsia)
- Performing a biological monitoring of blood (creatinine, LDL cholesterol, fasting glucose, albuminuria creatinuria ratio)(Up to one year following pre eclampsia)
- Screening and management of possible smoking(Up to one year following pre eclampsia)
- Cardiovascular risk assessment by the patient(Up to 5 years following pre eclampsia)
- Knowledge of pre-eclampsia status(Up to 5 years following pre eclampsia)
- Performing a self-measurement of blood pressure(Up to one year following pre eclampsia)
- Rate of stroke following pre-eclampsia(Up to 5 years following pre eclampsia)
- Rate of coronary accident following pre-eclampsia(Up to 5 years following pre eclampsia)
- Cardiovascular risk assessment by the general practitioner(Up to 5 years following pre eclampsia)
- Rate of hypertension following pre-eclampsia(Up to 5 years following pre eclampsia)
- Performing a cardiological consultation(Up to one year following pre eclampsia)
- Performing a ambulatory measurement of blood pressure(Up to one year following pre eclampsia)
研究者
Jean-Marc BOIVIN
Principal investigator
Central Hospital, Nancy, France